Xu Q - Search Results

1

Hypoxia‑inducible factors in hepatocellular carcinoma (Review).

Guo Y, Xiao Z, Yang L, Gao Y, Zhu Q, Hu L, Huang D, Xu Q. Guo Y, et al. Among authors: xu q. Oncol Rep. 2020 Jan;43(1):3-15. doi: 10.3892/or.2019.7397. Epub 2019 Nov 1. Oncol Rep. 2020. PMID: 31746396 Free PMC article. Review.

2

Role of the Hedgehog pathway in hepatocellular carcinoma (review).

Zheng X, Zeng W, Gai X, Xu Q, Li C, Liang Z, Tuo H, Liu Q. Zheng X, et al. Among authors: xu q. Oncol Rep. 2013 Nov;30(5):2020-6. doi: 10.3892/or.2013.2690. Epub 2013 Aug 22. Oncol Rep. 2013. PMID: 23970376 Review.

3

PKM2 regulates Gli1 expression in hepatocellular carcinoma.

Xu Q, Liu X, Zheng X, Yao Y, Liu Q. Xu Q, et al. Oncol Lett. 2014 Nov;8(5):1973-1979. doi: 10.3892/ol.2014.2441. Epub 2014 Aug 12. Oncol Lett. 2014. PMID: 25289083 Free PMC article.

4

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.

Xu Q, Zhang M, Tu J, Pang L, Cai W, Liu X. Xu Q, et al. Oncol Rep. 2015 Oct;34(4):2054-64. doi: 10.3892/or.2015.4175. Epub 2015 Aug 5. Oncol Rep. 2015. Retraction in: Oncol Rep. 2023 Feb;49(2):38. doi: 10.3892/or.2023.8475 PMID: 26252254 Retracted.

5

HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma.

Liu X, Chen S, Tu J, Cai W, Xu Q. Liu X, et al. Among authors: xu q. Int J Mol Med. 2016 Mar;37(3):825-35. doi: 10.3892/ijmm.2016.2482. Epub 2016 Feb 5. Int J Mol Med. 2016. PMID: 26846697

6

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.

Ye S, Zhao XY, Hu XG, Li T, Xu QR, Yang HM, Huang DS, Yang L. Ye S, et al. Oncol Rep. 2017 Apr;37(4):2215-2226. doi: 10.3892/or.2017.5494. Epub 2017 Mar 8. Oncol Rep. 2017. PMID: 28350084 Free PMC article.

7

MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.

Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K. Xu Q, et al. Mol Cancer. 2017 Jun 12;16(1):103. doi: 10.1186/s12943-017-0675-y. Mol Cancer. 2017. PMID: 28606154 Free PMC article.

8

microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma.

Liu X, Yang L, Tu J, Cai W, Zhang M, Shou Z, Yao Y, Xu Q. Liu X, et al. Among authors: xu q. Oncotarget. 2017 Sep 23;8(50):87737-87749. doi: 10.18632/oncotarget.21209. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152116 Free PMC article.

9

HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.

Xu Q, Tu J, Dou C, Zhang J, Yang L, Liu X, Lei K, Liu Z, Wang Y, Li L, Bao H, Wang J, Tu K. Xu Q, et al. Mol Cancer. 2017 Dec 20;16(1):178. doi: 10.1186/s12943-017-0748-y. Mol Cancer. 2017. PMID: 29262861 Free PMC article.

10

MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.

Liu Z, Wang Y, Dou C, Sun L, Li Q, Wang L, Xu Q, Yang W, Liu Q, Tu K. Liu Z, et al. Among authors: xu q. J Exp Clin Cancer Res. 2018 Mar 6;37(1):49. doi: 10.1186/s13046-018-0717-3. J Exp Clin Cancer Res. 2018. Retraction in: J Exp Clin Cancer Res. 2022 Sep 13;41(1):272. doi: 10.1186/s13046-022-02487-y PMID: 29510736 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,490 results

Search Page

Filters